Carl Uli Bialucha - Concepedia

Concepedia

Author

Carl Uli Bialucha

University College London ORCID

Also Known As

C. Uli Bialucha, C.U. Bialucha, CU Bialucha, Carl Bialucha, Carl U. Bialucha, Carl Uli Bialucha, Uli Bialucha, Uli Carl Bialucha

117

Publications

1.2K

Citations

13

H-Index

30

Concepts

All Affiliations

University College London MRC Laboratory for Molecular Cell Biology Novartis (United States)Howard Hughes Medical Institute Novartis Institutes for BioMedical Research

CU

About

Carl Uli Bialucha is an author at University College London specializing in medicine, cell biology, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	650
2	Cell Biology	4	4	628
3	Cellular Physiology	2	2	342
4	Natural Sciences	1	1	85
5	Biomolecular Engineering	1	1	22

Carl Uli Bialucha

×

13

Publications

1.2K

Citations

13

H-Index

	Year	Citations
Rap1 Regulates the Formation of E-Cadherin-Based Cell-Cell Contacts Catherine Hogan, Norberto Serpente, Patricia Cogram, Molecular and Cellular Biology Exchange FactorSignal TransductionE-cadherin-based Cell-cell ContactsIntimate Cell-cell ContactsCell Interaction	2004	257
Involvement of Lgl and Mahjong/VprBP in Cell Competition Yoichiro Tamori, Carl Uli Bialucha, Aiguo Tian, PLoS Biology	2010	173
Functional Identification of Tumor-Suppressor Genes through an In Vivo RNA Interference Screen in a Mouse Lymphoma Model Anka Bric, Cornelius Miething, Carl Uli Bialucha, Cancer Cell Systems BiologyFunctional GenomicsGeneticsTranscriptomics TechnologyFunctional Identification	2009	165
An Antibody That Locks HER3 in the Inactive Conformation Inhibits Tumor Growth Driven by HER2 or Neuregulin Andrew P. Garner, Carl Uli Bialucha, Elizabeth R. Sprague, Cancer Research Her2/her3 DimerizationMedicineInactive ConformationReceptor Tyrosine KinaseImmunology	2013	121
Combination of Antibody That Inhibits Ligand-Independent HER3 Dimerization and a p110α Inhibitor Potently Blocks PI3K Signaling and Growth of HER2+ Breast Cancers Joan T. Garrett, Cammie R. Sutton, Richard Kurupi, Cancer Research	2013	87
Casein Kinase 1 Is a Novel Negative Regulator of E-Cadherin-Based Cell-Cell Contacts Sophie Dupré‐Crochet, Angélica Figueroa, Catherine Hogan, Molecular and Cellular Biology E-cadherin-based Cell-cell ContactsCell AdhesionClassical CadherinsMolecular BiologyCell Junctions	2007	85
Reversible Kinetic Analysis of Myc Targets <i>In vivo</i> Provides Novel Insights into Myc-Mediated Tumorigenesis Elizabeth R. Lawlor, Laura Soucek, Lamorna Brown Swigart, Cancer Research	2006	75
Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas Saya H. Ebbesen, Maurizio Scaltriti, Carl Uli Bialucha, Proceedings of the National Academy of Sciences	2016	71
Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers Carl Uli Bialucha, Scott D. Collins, Xiao Li, Cancer Discovery	2017	52
Nicotinamide Phosphoribosyltransferase Inhibitor as a Novel Payload for Antibody–Drug Conjugates Alexei S. Karpov, Tinya J. Abrams, Suzanna Clark, ACS Medicinal Chemistry Letters	2018	41

Page 1